TY - JOUR TI - Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14 AU - Tomasek, Kathrin AU - Leithner, Alexander AU - Glatzova, Ivana AU - Lukesch, Michael S AU - Guet, Calin C AU - Sixt, Michael A2 - Zanoni, Ivan A2 - Rothlin, Carla V VL - 11 PY - 2022 DA - 2022/07/26 SP - e78995 C1 - eLife 2022;11:e78995 DO - 10.7554/eLife.78995 UR - https://doi.org/10.7554/eLife.78995 AB - A key attribute of persistent or recurring bacterial infections is the ability of the pathogen to evade the host’s immune response. Many Enterobacteriaceae express type 1 pili, a pre-adapted virulence trait, to invade host epithelial cells and establish persistent infections. However, the molecular mechanisms and strategies by which bacteria actively circumvent the immune response of the host remain poorly understood. Here, we identified CD14, the major co-receptor for lipopolysaccharide detection, on mouse dendritic cells (DCs) as a binding partner of FimH, the protein located at the tip of the type 1 pilus of Escherichia coli. The FimH amino acids involved in CD14 binding are highly conserved across pathogenic and non-pathogenic strains. Binding of the pathogenic strain CFT073 to CD14 reduced DC migration by overactivation of integrins and blunted expression of co-stimulatory molecules by overactivating the NFAT (nuclear factor of activated T-cells) pathway, both rate-limiting factors of T cell activation. This response was binary at the single-cell level, but averaged in larger populations exposed to both piliated and non-piliated pathogens, presumably via the exchange of immunomodulatory cytokines. While defining an active molecular mechanism of immune evasion by pathogens, the interaction between FimH and CD14 represents a potential target to interfere with persistent and recurrent infections, such as urinary tract infections or Crohn’s disease. KW - microbe KW - pathogenesis KW - immunity JF - eLife SN - 2050-084X PB - eLife Sciences Publications, Ltd ER -